{"id":"W2998689694","doi":"10.1200/jco.2013.31.15_suppl.5042","title":"NCIC CTG, IND-205: A phase II study of PX-866 in patients with recurrent or metastatic castration-resistant prostate cancer (CRPC).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Baker Hughes (Canada); Queen Elizabeth II Health Sciences Centre; BC Cancer Agency; Princess Margaret Cancer Centre; Interior Health; Cancer Care South East; London Health Sciences Centre; Queen's University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Prostate cancer; Internal medicine; Clinical endpoint; Nausea; Oncology; Adverse effect; Phases of clinical research; Docetaxel; Cancer; Neutropenia; Gastroenterology; Toxicity; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001409801,0.0018086,0.001667429,0.000634379,0.0005295158,0.0007491319,0.001276703,0.001238117,0.004199988],"category_scores_gemma":[0.0007491187,0.0005998762,0.0009560092,0.0006888526,0.0009422236,0.000564165,0.0003538943,0.00282065,0.001487262],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008419473,"about_ca_system_score_gemma":0.002218839,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003702145,"about_ca_topic_score_gemma":0.009640943,"domain_scores_codex":[0.9996004,0.0002212768,0.00001575437,0.00004528567,0.00004165404,0.00007569703],"domain_scores_gemma":[0.9994766,0.00007864156,0.00008061259,0.00003886415,0.00003280886,0.0002924969],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5414199,0.1238106,0.01612621,0.00246731,0.001598867,0.001354981,0.0007606887,0.006656975,0.09428009,0.0006563203,0.01582984,0.1950383],"study_design_scores_gemma":[0.4963712,0.4691299,0.0241065,0.00006886883,0.0004041307,0.0008916506,0.00007862757,0.001621038,0.003356807,0.0001167047,0.003809651,0.0000449458],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9891732,0.002331917,0.0005150724,0.0005166457,0.0001056873,0.002846582,0.001347948,0.0002253071,0.002937653],"genre_scores_gemma":[0.9820107,0.002861562,0.001908599,0.001180973,0.0001787485,0.002626535,0.004540587,0.00005519454,0.004637106],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004199988,"threshold_uncertainty_score":0.01405036,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08646921911035348,"score_gpt":0.4616130974416957,"score_spread":0.3751438783313422,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}